EDMONTON, Alberta–May 24, 2023– mmHg Inc., a physician-led digital health company has announced a new partnership with AllianceChicago, a national network of more than 70 community health centers (CHCs) across 18 states. This partnership aims to provide CHCs with exclusive access to Sphygmo, a revolutionary self-monitored blood pressure (SMBP) and vital signs platform. Sphygmo is a cutting-edge technology that enables healthcare providers to effectively manage and monitor blood pressure, glucose, weight, oxygen saturation, respiratory rate, and temperature in their patients.
With the increasing prevalence of chronic diseases like hypertension, it has become more important than ever to monitor and manage vital signs regularly. The COVID-19 pandemic has further highlighted the importance of remote monitoring, as many patients are unable to visit healthcare facilities due to safety concerns. Sphygmo offers a solution to these challenges by providing patients with the ability to monitor their vital signs from the comfort of their own homes, while also allowing healthcare providers to efficiently manage their patients’ health remotely.
“We are thrilled to partner with AllianceChicago and provide community health centers access to Sphygmo,” said Dr. Raj Padwal, CEO of mmHg Inc. “Sphygmo has been shown to improve patient outcomes by enabling healthcare providers to monitor their patients’ vital signs more effectively. We look forward to working with AllianceChicago to expand access to this innovative technology and improve healthcare outcomes for Federally Qualified Health Center (FQHC) patients across the country.”
Sphygmo is designed to be user-friendly and accessible to all patients, regardless of their age or technical proficiency. The platform provides patients with step-by-step instructions for monitoring their vital signs and allows them to share their data with their healthcare providers in real-time. Healthcare providers can use Sphygmo to track their patients’ progress and adjust treatment plans as necessary, all while saving time and resources.
“AllianceChicago is proud to partner with mmHg Inc. and offer our community health centers access to Sphygmo,” said Dr. Fred Rachman, CEO of AllianceChicago. “This innovative technology will enable health centers to affordably provide more efficient and effective care to their patients, especially those with chronic conditions. We are confident that Sphygmo will make a significant impact in improving health outcomes for patients.”
About mmHg Inc.
mmHg Inc. is a physician-led digital health company that is focused on developing innovative solutions to improve healthcare outcomes. The company offers cardiometabolic software platforms that automate and simplify care provision yet ensure that care is evidence-based. Sphygmo, is a self-monitored blood pressure (SMBP) and vital signs platform that enables patients to monitor their vital signs from the comfort of their own homes while allowing healthcare providers to efficiently manage their patients’ health remotely.
AllianceChicago (AC) is a health center-controlled network and practice-based research network, linking more than 70 organizations serving Federally Qualified Health Center (FQHC) patients across Illinois and 17 other states. It provides support for health information technology that enables practice improvement, advanced data analytics and curates a comprehensive health database comprising over 4 million highly diverse patients. The communities represented include urban and rural populations, low‐income and uninsured individuals, racial and ethnic minorities, the LGBTQ community, and refugee and homeless populations. For more information, please visit www.alliancechicago.org.